Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,758
Total Claims
$725K
Drug Cost
623
Beneficiaries
$1,164
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-15%
Opioid rate vs peers
1.9% vs 2.2% avg
-18%
Cost per patient vs peers
$1,164 vs $1,411 avg
-14%
Brand preference vs peers
9.2% vs 10.6% avg
Opioid Prescribing
1.9%
Opioid Rate
166
Opioid Claims
$3,058
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 789 claims · $557K
Generic: 7,826 claims · $158K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 131 | $152K |
| Insulin Glargine,hum.Rec.Anlog | 95 | $81K |
| Rivaroxaban | 37 | $53K |
| Insulin Aspart | 24 | $28K |
| Semaglutide | 19 | $27K |
| Empagliflozin | 22 | $21K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $14K |
| Fluticasone Propionate | 28 | $13K |
| Atorvastatin Calcium | 621 | $11K |
| Insulin Lispro | 15 | $11K |
| Budesonide/Formoterol Fumarate | 19 | $11K |
| Omeprazole | 498 | $9,338 |
| Insulin Glargine,hum.Rec.Anlog | 16 | $7,079 |
| Metoprolol Succinate | 287 | $6,900 |
| Levothyroxine Sodium | 318 | $6,285 |
Prescribing Profile
Patient Profile
77
Avg Age
48%
Female
1.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data